The global market for Molecular Infectious Disease Testing was valued at US$ 441 million in the year 2024 and is projected to reach a revised size of US$ 631 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.
North American market for Molecular Infectious Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Molecular Infectious Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Molecular Infectious Disease Testing include Danaher, Roche, ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ, Hologic, Abbott, Thermo Fisher Scientific, QIAGEN, Revvity, Grifols, Seegene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Molecular Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Infectious Disease Testing.
The Molecular Infectious Disease Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Infectious Disease Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Danaher
Roche
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Hologic
Abbott
Thermo Fisher Scientific
QIAGEN
Revvity
Grifols
Seegene
DiaSorin
Siemens Healthineers
BD
QuidelOrtho
Bruker
Genetic Signatures
Co-Diagnostics
Vela Diagnostics
Molbio Diagnostics
Savyon Diagnostics
Uniogen Oy
geneOmbio Technologies
Advanced Molecular Diagnostics
altona Diagnostics
GeneFirst
Segment by Type
Multiplex Testing
Singleplex Testing
Segment by Application
Diagnostic Laboratories
Hospitals and Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Infectious Disease Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Infectious Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Molecular Infectious Disease Testing Market Overview
1.1 Product Definition
1.2 Molecular Infectious Disease Testing by Type
1.2.1 Global Molecular Infectious Disease Testing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Multiplex Testing
1.2.3 Singleplex Testing
1.3 Molecular Infectious Disease Testing by Application
1.3.1 Global Molecular Infectious Disease Testing Market Value by Application (2024 VS 2031)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Clinics
1.3.4 Others
1.4 Global Molecular Infectious Disease Testing Market Size Estimates and Forecasts
1.4.1 Global Molecular Infectious Disease Testing Revenue 2020-2031
1.4.2 Global Molecular Infectious Disease Testing Sales 2020-2031
1.4.3 Global Molecular Infectious Disease Testing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Molecular Infectious Disease Testing Market Competition by Manufacturers
2.1 Global Molecular Infectious Disease Testing Sales Market Share by Manufacturers (2020-2025)
2.2 Global Molecular Infectious Disease Testing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Molecular Infectious Disease Testing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Molecular Infectious Disease Testing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Infectious Disease Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Infectious Disease Testing, Product Type & Application
2.7 Global Key Manufacturers of Molecular Infectious Disease Testing, Date of Enter into This Industry
2.8 Global Molecular Infectious Disease Testing Market Competitive Situation and Trends
2.8.1 Global Molecular Infectious Disease Testing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Molecular Infectious Disease Testing Players Market Share by Revenue
2.8.3 Global Molecular Infectious Disease Testing Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Molecular Infectious Disease Testing Market Scenario by Region
3.1 Global Molecular Infectious Disease Testing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Molecular Infectious Disease Testing Sales by Region: 2020-2031
3.2.1 Global Molecular Infectious Disease Testing Sales by Region: 2020-2025
3.2.2 Global Molecular Infectious Disease Testing Sales by Region: 2026-2031
3.3 Global Molecular Infectious Disease Testing Revenue by Region: 2020-2031
3.3.1 Global Molecular Infectious Disease Testing Revenue by Region: 2020-2025
3.3.2 Global Molecular Infectious Disease Testing Revenue by Region: 2026-2031
3.4 North America Molecular Infectious Disease Testing Market Facts & Figures by Country
3.4.1 North America Molecular Infectious Disease Testing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Molecular Infectious Disease Testing Sales by Country (2020-2031)
3.4.3 North America Molecular Infectious Disease Testing Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Infectious Disease Testing Market Facts & Figures by Country
3.5.1 Europe Molecular Infectious Disease Testing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Molecular Infectious Disease Testing Sales by Country (2020-2031)
3.5.3 Europe Molecular Infectious Disease Testing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Infectious Disease Testing Market Facts & Figures by Region
3.6.1 Asia Pacific Molecular Infectious Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Molecular Infectious Disease Testing Sales by Region (2020-2031)
3.6.3 Asia Pacific Molecular Infectious Disease Testing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Molecular Infectious Disease Testing Market Facts & Figures by Country
3.7.1 Latin America Molecular Infectious Disease Testing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Molecular Infectious Disease Testing Sales by Country (2020-2031)
3.7.3 Latin America Molecular Infectious Disease Testing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Molecular Infectious Disease Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Infectious Disease Testing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Molecular Infectious Disease Testing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Molecular Infectious Disease Testing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Infectious Disease Testing Sales by Type (2020-2031)
4.1.1 Global Molecular Infectious Disease Testing Sales by Type (2020-2025)
4.1.2 Global Molecular Infectious Disease Testing Sales by Type (2026-2031)
4.1.3 Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2031)
4.2 Global Molecular Infectious Disease Testing Revenue by Type (2020-2031)
4.2.1 Global Molecular Infectious Disease Testing Revenue by Type (2020-2025)
4.2.2 Global Molecular Infectious Disease Testing Revenue by Type (2026-2031)
4.2.3 Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2031)
4.3 Global Molecular Infectious Disease Testing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Molecular Infectious Disease Testing Sales by Application (2020-2031)
5.1.1 Global Molecular Infectious Disease Testing Sales by Application (2020-2025)
5.1.2 Global Molecular Infectious Disease Testing Sales by Application (2026-2031)
5.1.3 Global Molecular Infectious Disease Testing Sales Market Share by Application (2020-2031)
5.2 Global Molecular Infectious Disease Testing Revenue by Application (2020-2031)
5.2.1 Global Molecular Infectious Disease Testing Revenue by Application (2020-2025)
5.2.2 Global Molecular Infectious Disease Testing Revenue by Application (2026-2031)
5.2.3 Global Molecular Infectious Disease Testing Revenue Market Share by Application (2020-2031)
5.3 Global Molecular Infectious Disease Testing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Danaher
6.1.1 Danaher Company Information
6.1.2 Danaher Description and Business Overview
6.1.3 Danaher Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Danaher Molecular Infectious Disease Testing Product Portfolio
6.1.5 Danaher Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Molecular Infectious Disease Testing Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
6.3.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Information
6.3.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Description and Business Overview
6.3.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Molecular Infectious Disease Testing Product Portfolio
6.3.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Developments/Updates
6.4 Hologic
6.4.1 Hologic Company Information
6.4.2 Hologic Description and Business Overview
6.4.3 Hologic Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hologic Molecular Infectious Disease Testing Product Portfolio
6.4.5 Hologic Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Molecular Infectious Disease Testing Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Company Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Molecular Infectious Disease Testing Product Portfolio
6.6.5 Thermo Fisher Scientific Recent Developments/Updates
6.7 QIAGEN
6.7.1 QIAGEN Company Information
6.7.2 QIAGEN Description and Business Overview
6.7.3 QIAGEN Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 QIAGEN Molecular Infectious Disease Testing Product Portfolio
6.7.5 QIAGEN Recent Developments/Updates
6.8 Revvity
6.8.1 Revvity Company Information
6.8.2 Revvity Description and Business Overview
6.8.3 Revvity Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Revvity Molecular Infectious Disease Testing Product Portfolio
6.8.5 Revvity Recent Developments/Updates
6.9 Grifols
6.9.1 Grifols Company Information
6.9.2 Grifols Description and Business Overview
6.9.3 Grifols Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Grifols Molecular Infectious Disease Testing Product Portfolio
6.9.5 Grifols Recent Developments/Updates
6.10 Seegene
6.10.1 Seegene Company Information
6.10.2 Seegene Description and Business Overview
6.10.3 Seegene Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Seegene Molecular Infectious Disease Testing Product Portfolio
6.10.5 Seegene Recent Developments/Updates
6.11 DiaSorin
6.11.1 DiaSorin Company Information
6.11.2 DiaSorin Description and Business Overview
6.11.3 DiaSorin Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 DiaSorin Molecular Infectious Disease Testing Product Portfolio
6.11.5 DiaSorin Recent Developments/Updates
6.12 Siemens Healthineers
6.12.1 Siemens Healthineers Company Information
6.12.2 Siemens Healthineers Description and Business Overview
6.12.3 Siemens Healthineers Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Siemens Healthineers Molecular Infectious Disease Testing Product Portfolio
6.12.5 Siemens Healthineers Recent Developments/Updates
6.13 BD
6.13.1 BD Company Information
6.13.2 BD Description and Business Overview
6.13.3 BD Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BD Molecular Infectious Disease Testing Product Portfolio
6.13.5 BD Recent Developments/Updates
6.14 QuidelOrtho
6.14.1 QuidelOrtho Company Information
6.14.2 QuidelOrtho Description and Business Overview
6.14.3 QuidelOrtho Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.14.4 QuidelOrtho Molecular Infectious Disease Testing Product Portfolio
6.14.5 QuidelOrtho Recent Developments/Updates
6.15 Bruker
6.15.1 Bruker Company Information
6.15.2 Bruker Description and Business Overview
6.15.3 Bruker Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bruker Molecular Infectious Disease Testing Product Portfolio
6.15.5 Bruker Recent Developments/Updates
6.16 Genetic Signatures
6.16.1 Genetic Signatures Company Information
6.16.2 Genetic Signatures Description and Business Overview
6.16.3 Genetic Signatures Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Genetic Signatures Molecular Infectious Disease Testing Product Portfolio
6.16.5 Genetic Signatures Recent Developments/Updates
6.17 Co-Diagnostics
6.17.1 Co-Diagnostics Company Information
6.17.2 Co-Diagnostics Description and Business Overview
6.17.3 Co-Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Co-Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.17.5 Co-Diagnostics Recent Developments/Updates
6.18 Vela Diagnostics
6.18.1 Vela Diagnostics Company Information
6.18.2 Vela Diagnostics Description and Business Overview
6.18.3 Vela Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Vela Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.18.5 Vela Diagnostics Recent Developments/Updates
6.19 Molbio Diagnostics
6.19.1 Molbio Diagnostics Company Information
6.19.2 Molbio Diagnostics Description and Business Overview
6.19.3 Molbio Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Molbio Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.19.5 Molbio Diagnostics Recent Developments/Updates
6.20 Savyon Diagnostics
6.20.1 Savyon Diagnostics Company Information
6.20.2 Savyon Diagnostics Description and Business Overview
6.20.3 Savyon Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Savyon Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.20.5 Savyon Diagnostics Recent Developments/Updates
6.21 Uniogen Oy
6.21.1 Uniogen Oy Company Information
6.21.2 Uniogen Oy Description and Business Overview
6.21.3 Uniogen Oy Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Uniogen Oy Molecular Infectious Disease Testing Product Portfolio
6.21.5 Uniogen Oy Recent Developments/Updates
6.22 geneOmbio Technologies
6.22.1 geneOmbio Technologies Company Information
6.22.2 geneOmbio Technologies Description and Business Overview
6.22.3 geneOmbio Technologies Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.22.4 geneOmbio Technologies Molecular Infectious Disease Testing Product Portfolio
6.22.5 geneOmbio Technologies Recent Developments/Updates
6.23 Advanced Molecular Diagnostics
6.23.1 Advanced Molecular Diagnostics Company Information
6.23.2 Advanced Molecular Diagnostics Description and Business Overview
6.23.3 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.23.5 Advanced Molecular Diagnostics Recent Developments/Updates
6.24 altona Diagnostics
6.24.1 altona Diagnostics Company Information
6.24.2 altona Diagnostics Description and Business Overview
6.24.3 altona Diagnostics Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.24.4 altona Diagnostics Molecular Infectious Disease Testing Product Portfolio
6.24.5 altona Diagnostics Recent Developments/Updates
6.25 GeneFirst
6.25.1 GeneFirst Company Information
6.25.2 GeneFirst Description and Business Overview
6.25.3 GeneFirst Molecular Infectious Disease Testing Sales, Revenue and Gross Margin (2020-2025)
6.25.4 GeneFirst Molecular Infectious Disease Testing Product Portfolio
6.25.5 GeneFirst Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Infectious Disease Testing Industry Chain Analysis
7.2 Molecular Infectious Disease Testing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Infectious Disease Testing Production Mode & Process Analysis
7.4 Molecular Infectious Disease Testing Sales and Marketing
7.4.1 Molecular Infectious Disease Testing Sales Channels
7.4.2 Molecular Infectious Disease Testing Distributors
7.5 Molecular Infectious Disease Testing Customer Analysis
8 Molecular Infectious Disease Testing Market Dynamics
8.1 Molecular Infectious Disease Testing Industry Trends
8.2 Molecular Infectious Disease Testing Market Drivers
8.3 Molecular Infectious Disease Testing Market Challenges
8.4 Molecular Infectious Disease Testing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Danaher
Roche
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Hologic
Abbott
Thermo Fisher Scientific
QIAGEN
Revvity
Grifols
Seegene
DiaSorin
Siemens Healthineers
BD
QuidelOrtho
Bruker
Genetic Signatures
Co-Diagnostics
Vela Diagnostics
Molbio Diagnostics
Savyon Diagnostics
Uniogen Oy
geneOmbio Technologies
Advanced Molecular Diagnostics
altona Diagnostics
GeneFirst
Ìý
Ìý
*If Applicable.
